In total, 11 569 individuals had no CD4 and CD8 cell counts or viral load measurements recorded after January 2012, never started ART, or had < 12 months follow-up and were excluded, leaving 19 247 individuals and 730 malignancies for analysis (Figure 1). The gene discussed is CD8A; the disease is cancer.